RECOMBINANT WRL 105 STRAIN LIVE ATTENUATED INFLUENZA VACCINE

作者: C.A. Morris , V.M. Stealey , D.S. Freestone , P.R. Oliver

DOI: 10.1016/S0140-6736(75)90670-4

关键词: ImmunologyVirologyAntibodyAntigenVaccinationImmunogenicityMedicineLive attenuated influenza vaccinePlaceboIncidence (epidemiology)Recombinant DNAGeneral Medicine

摘要: Abstract The immunogenicity, reactivity, and transmissibility of recombinant WRL 105 (H3N2) (A/Okuda/57 × A/Finland/4/74) strain live attenuated influenza virus vaccine were studied in adult male volunteers a residential community rural England. Thirteen received single dose 10 7.0 E.I.D. 50 administered as nose drops, twelve placebo. Nine (82%) eleven with initial antibody titres ≤1/96 showed significant response to vaccination, but there was no evidence transmission those who incidence nature reactions similar shown confer protection against natural infection exhibiting antigenic characteristics equivalent A/ Scotland/840/74.

参考文章(6)
D. McCahon, G. C. Schild, Segregation of Antigenic and Biological Characteristics during Influenza Virus Recombination Journal of General Virology. ,vol. 15, pp. 73- 77 ,(1972) , 10.1099/0022-1317-15-1-73
Roden At, National experience with Hong Kong influenza in the United Kingdom, 1968-69 Bulletin of The World Health Organization. ,vol. 41, pp. 375- 380 ,(1969)
KANZEN NAKAMURA, YOSHIOMI OKUNO, Vaccination with live attenuated influenza virus at the Osaka University Hospital in 1960 Viruses. ,vol. 11, pp. 349- 354 ,(1961) , 10.2222/JSV.11.349